Thus, a screening test that will include the ERCC1 (rs3212986), ERCC2 (rs13181), XRCC1 (rs25487), and XRCC3 (rs861539) genes may well be helpful for the prevention and earliest treatment of patients with glioma susceptibility. Here, XRCC3 is linked to glioma.